2024 annual financial data
Cellectar Biosciences 2024 Operating margin
Cellectar Biosciences 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -51,777,698 USD and net income was -44,581,446 USD.
Operating cash flow was -47,583,001 USD.
Get free Cellectar Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -51,777,698 USD
- Net income
- -44,581,446 USD
- Operating cash flow
- -47,583,001 USD